Keyphrases
Pancreas Allograft
100%
Cyclosporine
100%
Sirolimus
100%
Graft Survival
100%
Immune Regulation
100%
Thymoglobulin
100%
HLA Antibodies
100%
Suppressor Cells
100%
Pancreas
66%
Kidney
66%
Immunomodulatory
66%
Donor-specific
66%
Flow Cytometry
33%
Clinical Outcomes
33%
Immune Response
33%
Immunosuppression
33%
Acute Rejection
33%
Transplant Recipients
33%
Kidney Transplant Recipients
33%
Sepsis
33%
Graft Function
33%
Corticosteroids
33%
Cell Function
33%
Antibody Response
33%
Graft Loss
33%
Pancreas Transplant
33%
Pancreas Graft
33%
Acute Rejection Episode
33%
Clinical Consequences
33%
CD4 Count
33%
Non-donors
33%
No Adverse Effect
33%
Cell-based Assay
33%
T Cell Subsets
33%
Reduced Dose
33%
Immune Monitoring
33%
Specific Flow
33%
Cell Activity
33%
Specific Immunity
33%
Monitoring Study
33%
Induction Protocol
33%
CD8 Count
33%
Cross-matching
33%
Immunology and Microbiology
Allograft
100%
Ciclosporin
100%
Sirolimus
100%
Pancreas
100%
Immunoregulation
100%
Anti-Thymocyte Globulin
100%
HLA Antibody
100%
Suppressor Cell
100%
Pancreas Transplantation
66%
Acute Graft Rejection
66%
Cell Function
33%
Immune Response
33%
Immunosuppression
33%
Immunity
33%
Antibody Response
33%
CD3 Antigen
33%
Adaptive Immune System
33%
Cell Activity
33%
T Cell Subset
33%
CD4 Lymphocyte Count
33%
Cell Assay
33%
CD8 Lymphocyte Count
33%